Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2012
08/08/2012EP1921085B1 Therapeutic agent for hypertension
08/08/2012EP1838296B1 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
08/08/2012EP1824855B1 Novel pyrrolo [3, 2-d]pyrimidin-4-one derivatives and their use in therapy
08/08/2012EP1614419B1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012EP0837938B1 Use of mp52 or mp121 for treating and preventing diseases of the nervous system
08/08/2012CN1930288B Cells of which genome is modified
08/08/2012CN1439375B Dehydroepiandrosterone treating use and transfer system
08/08/2012CN102628044A RNAi modulation of APOB and uses thereof
08/08/2012CN102627680A Ginsenoside Rg1 compound and pharmaceutical composition containing the same
08/08/2012CN102627676A C-aryl glucoside sglt2 inhibitors and method
08/08/2012CN102627669A Phosphate ester-containing piperazine derivative and preparation method as well as application thereof
08/08/2012CN102627638A Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor
08/08/2012CN102627620A One type of benzofuran derivatives and medical application thereof
08/08/2012CN102627613A 2-[(4,6-dimethyl pyrimidine-2-)oxyl]-3-cyano-3,3-dibenzyl propionic acid optical isomer, its preparation method and medical application
08/08/2012CN102627611A Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
08/08/2012CN102627609A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
08/08/2012CN102626510A Traditional Chinese medicine composite for treating diabetic cardiopathy and preparation method and applications of traditional Chinese medicine composite
08/08/2012CN102626497A Traditional Chinese medicine for treating diabetic foot
08/08/2012CN102626492A Externally used Chinese herbal medicine combination for treating thromboangitis obliterans
08/08/2012CN102626485A Pure Chinese medicine preparation for treating hypertension
08/08/2012CN102626480A Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof
08/08/2012CN102626476A Medicine for treating and preventing ischemic cardiovascular and cerebrovascular diseases
08/08/2012CN102626472A Medicine for treating acute cerebral hemorrhage and preparation method thereof
08/08/2012CN102626469A Method for preparing high-purity tea polyphenol in centrifuging, extracting and separating mode
08/08/2012CN102626459A Method for compound enzyme-hot water extraction of cortex phellodendri alkaloids
08/08/2012CN102626453A Method for preparing total alkaloids of uncaria
08/08/2012CN102626452A Hawthorn, radix puerariae, gingko and balsam pear four-in-one flavone capsule
08/08/2012CN102626450A Method for preparing total diterpenoids alkaloid in monkshood
08/08/2012CN102626449A Capsule for treating apoplexy hemiplegia
08/08/2012CN102626434A Preparing method for separating and purifying flavonoid compounds from micropore grass seed dregs
08/08/2012CN102626429A Method for water-bath extraction of castanea mollissina Blume involucre polyphenols
08/08/2012CN102626428A Ginkgo leaf extract osmotic pump controlled-release preparation and preparation method thereof
08/08/2012CN102626427A Ginkgo dipyridamole composition and preparation method of preparation thereof
08/08/2012CN102626396A Metoprolol slow-release tablet and preparation method thereof
08/08/2012CN102626395A Solid preparation of aliskiren-valsartan pharmaceutical composition liposome
08/08/2012CN102626391A Aliskiren-hydrochlorothiazide drug combination liposome solid preparation
08/08/2012CN102626390A Gastrodin multiphase liposome injection
08/08/2012CN102626383A Bilobalide injection and preparation method thereof
08/08/2012CN102626382A Method for preparing sinomenine hydrochloride infusion solution and freeze-dried powder injection
08/08/2012CN102626162A Nutrition food heart-nourishing tea granule for nourishing hearts
08/08/2012CN102266524B Traditional Chinese medicine for treating chronic heart failure and preparation method thereof
08/08/2012CN102225122B Caffeine-free tea polyphenol and preparation method thereof
08/08/2012CN102210799B Medicament for treating peripheral vascular disease
08/08/2012CN102205013B Method for processing giant typhonium rhizome
08/08/2012CN102188488B Pharmaceutical for treating varicose vein
08/08/2012CN102125662B Compound traditional Chinese medicine for treating apoplexia and preparation method and application thereof
08/08/2012CN101889079B A method for constructing human placental mesenchymal cells library which is suitable for clinical applicationc
08/08/2012CN101869284B Health food for assisting blood pressure reduction by utilizing green tea extract and preparation method thereof
08/08/2012CN101828715B Health-care food for patient with hyperlipidemia, hypertension and hypercholesterolemia
08/08/2012CN101822690B Composition of dextran 40 and sodium lactate Ringer' solution and preparation method
08/08/2012CN101773529B Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation thereof
08/08/2012CN101690795B Tianshen vessel-freeing granules for treating cardiovascular and cerebrovascular diseases
08/08/2012CN101647856B Medicine for treating coronary heart disease and preparation method thereof
08/08/2012CN101543298B Rutin chewing agent and method for preparing same
08/08/2012CN101486705B Preparation of Azelnidipine alpha crystal form
08/08/2012CN101479268B 2-0'-methyladenosine derivatives and their use as agonists or antagonists of an adenosine receptor
08/08/2012CN101243053B N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/08/2012CN101199594B Smoked lotion for treating hemorrhoid sausage disease and preparing method thereof
08/08/2012CN101195613B Compound with substituted tetratomic ring structure and medicine use thereof
08/08/2012CN101195612B Compound with substituted cyclobutane structure, production method and medicine use thereof
08/08/2012CN101148642B Probiotic/non-probiotic combinations
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236809 Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation
08/07/2012US8236804 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
08/07/2012US8236803 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
08/07/2012US8236798 Carboxamide compounds and their use as calpain inhibitors
08/07/2012US8236789 1-adamantyl azetidin-2-one derivatives and drugs containing same
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236048 Drug/drug delivery systems for the prevention and treatment of vascular disease
08/07/2012CA2606861C Stable nanoparticle formulations
08/07/2012CA2533181C Use of dapsone as neuroprotector in the brain stroke
08/07/2012CA2513544C An otorhinological delivery device
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2445421C Von willebrand factor (vwf)-cleaving protease
08/07/2012CA2438314C 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
08/02/2012WO2012103314A1 Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension
08/02/2012WO2012103305A1 Use of (s) - esmolol for controlling venous irritation associated with the treatment of a cardiac disorder
08/02/2012WO2012102555A2 Fucoidan for thrombolysis, derived from seaweed
08/02/2012WO2012102405A1 Ring-fused compound
08/02/2012WO2012102363A1 Drug delivery system and use of same
08/02/2012WO2012102361A1 Aromatase activator
08/02/2012WO2012102360A1 Morphinan derivative
08/02/2012WO2012101747A1 Tie2 ACTIVATOR, AGENT FOR MATURING, NORMALIZING OR STABILIZING BLOOD VESSELS, AGENT FOR STABILIZING LYMPHATIC VESSELS, PREPARATION FOR PREVENTING AND REDUCING WRINKLES, AND PREPARATION FOR REDUCING AND PREVENTING SWELLING
08/02/2012WO2012101741A1 Tie-2 activator, agent for maturation, normalization, or stabilization of blood vessels, lymph vessel stabilizing agent, wrinkle prevention/improvement agent, and edema improvement/prevention agent
08/02/2012WO2012101564A2 Anti-inflammatory compounds
08/02/2012WO2012101064A1 N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
08/02/2012WO2012101062A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
08/02/2012WO2012100704A1 Chiral low-toxicity cb1 receptor inhibitor, preparation method therefor, and use thereof
08/02/2012WO2012100654A1 Ribofuranosyl purine compound, preparation method therefor, and use thereof
08/02/2012WO2012100612A1 Extraction method, total saponin and use of ilex kudingcha c.j.tseng leaves
08/02/2012WO2012100459A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
08/02/2012WO2012100442A1 Plant extract composition used for preventing and treating arteriosclerosis and preparative method thereof
08/02/2012WO2012100436A1 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
08/02/2012WO2012100389A1 Triterpenoid saponin compounds, preparation methods and uses thereof
08/02/2012WO2012068209A3 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
08/02/2012WO2011095882A8 Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
08/02/2012US20120197059 Ubiquitin interacting motif peptides as cancer therapeutics
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120196937 Treatment of ophthalmic disorders using urea
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 1595